(Q39185302)

9 September 2017

title

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study (English)

1 reference

inflammatory bowel diseases

9 September 2017

main subject

0 references

0 references

4

1 reference

9 September 2017

6

Cem Gabay

1 reference

9 September 2017

3

Pascal Juillerat

1 reference

9 September 2017

5

Pierre Michetti

1 reference

Swiss IBD Cohort Study Group

9 September 2017

series ordinal

8

object named as

Swiss IBD Cohort Study Group

1 reference

9 September 2017

2

Nicolas Fournier

1 reference

9 September 2017

Saskia Ditisheim

1

1 reference

9 September 2017

Axel Finckh

series ordinal

7

1 reference

9 September 2017

publication date

4 August 2015

1 reference

Inflammatory Bowel Diseases

9 September 2017

published in

1 reference

9 September 2017

volume

21

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

2598-2604

1 reference

Rheumatic manifestations of inflammatory bowel disease

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Genetics of spondyloarthritis--beyond the MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

IBD and arthropathies: a practical approach to its diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Increased intestinal permeability in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Gut inflammation and spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Gut inflammation in the spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Gastrointestinal lesions associated with spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Performance of the assessment in Spondyloarthritis International Society classification for axial and peripheral spondyloarthritis in an established clinical cohort: comparison with criteria sets of Amor and the European Spondylarthropathy Study Gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

New tools for diagnosing spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Tobacco smoking and autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Cigarette smoking and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Smoking and spondyloarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Cigarette smoking and inflammation revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

Musculoskeletal Manifestations in a Population-based Cohort of Inflammatory Bowel Disease Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000548

10.1097/MIB.0000000000000548

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference